All Type of News
Will Baraclude generics surprise the market next year?
Will Baraclude generics, such as Dong-A ST’s Baracle and Hanmi Pharm’s Entecavir Tab, overcome the stronghold of Baraclude next year?
According to the industry concerned on the 15th, large hospitals, such as Seoul Na...
Febuxostat acquires the 13th exclusive sale product right
‘Febuxostat,’ which has been prohibited to sell due to the lawsuit winning of generic companies, was registered as the 13th exclusive sales pharmaceutical product.
The Ministry of Food and Drug Safety(MFDS) announced...
Korea Pharmaceutical Association President Chan-hwi Cho reelected
Chan-hwi Cho, President of Korean Pharmaceutical Association, got reelected.
President Chan-hwi Cho was elected for the next president as getting 54.9% of valid votes, 9,525 of the total 18,094 votes, in the 38th Kor...
Less sales positions lead to more researchers in pharmaceutical employment
Among various job positions in the pharmaceutical industry, sales positions are observed to decrease while researchers increased for the past 10 years.
Considering other job positions have similar ratios compared wit...
Co-marketed products experience frequent out-of-stocks, enraging pharmacies and wholesalers
Recently, products co-marketed by domestic and foreign pharmaceutical companies have been suffered from frequent out-of-stocks.
According to the pharmacy and pharmaceutical distribution fields on the 11th, ETC drugs,...
U.S. and Japanese ‘No. 1 ‘ painkillers fail in the domestic market
Global top painkiller brand, Advil; Japanese No. 1 painkiller brand, Bufferin.
Pfizer’s’ Advil,’ a painkiller sold in 50 different countries across the world, is a super-gigantic product recording more than USD 1 bil...
Amendment to the Pharmacist Affairs Law passed the general meeting
At the last general meeting of the 19th National Assembly, the amendments to the Pharmacist Affairs Law and the Medical Law, which includes revisions such as the DUR Enactment and the CSO Rebate Prohibition, passed th...
10th anniversary of Zydena, erectile dysfunction treatment
Dong-A ST(President and CEO Soo-hyung Kang) held a symposium to celebrate the 10th anniversary of the ‘Zydena’ commercialization, a erectile dysfunction treatment, by inviting 120 urologists at Samcheonggak in Seongbu...
Cialis launches counterattack against 21 domestic companies, filing appeal to Patent Court
Cialis, which has encountered the crisis of its generic products, is getting ready to launch a counterattack.
The company filed an appeal against the 21 companies at the Patent Court as protesting the Intellectual Pr...
Pharmaceutical industry expect next year’s market condition conservatively, setting target growth rates at 5-10%
Most pharmaceutical companies foresaw the next year’s pharmaceutical economy is unclear even worse than this year, and set their growth goal at 5% to 10%.
According to the industry concerned on the 9th, pharmaceutica...
